MANUEL ASTRUC: Open Payments
NPI 1700863255 · SARATOGA SPRINGS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,148 in 196 payments from 15 companies in 2025. Trend: 2023 $9,341 · 2024 $2,428 · 2025 $3,148
Food & beverage: $3,038Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $648 |
| Janssen Pharmaceuticals, Inc | 32 | $576 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $402 |
| Neurocrine BioSciences, Inc. | 25 | $298 |
| Teva Pharmaceuticals USA, Inc. | 17 | $273 |
| Vanda Pharmaceuticals Inc. | 16 | $217 |
| Axsome Therapeutics, Inc. | 14 | $204 |
| Lundbeck LLC | 12 | $163 |
| Alkermes, Inc. | 9 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
Products named: VRAYLAR, CAPLYTA, SPRAVATO, INGREZZA, FANAPT, INVEGA SUSTENNA, Auvelity, REXULTI.
Industry payments across NY — which companies pay providers there.
